Neuroinflammation lies at the intersection of immune signaling, neural circuitry, and disease progression. Over the past decade, extraordinary advances have deepened our understanding of microglial activation states, peripheral immune infiltration, cytokine signaling cascades, and the long-term consequences of inflammatory stress on cognition and behavior.

The challenge before us is clear:

• How do we move from descriptive findings to actionable therapeutic targets in brain tumors, migraine, sleep disorders, and epilepsy?
• How do we design interventions that modulate inflammatory pathways without disrupting essential neuroimmune communication in multiple sclerosis (MS), CIDP, epilepsy, headache disorders, and myasthenia gravis?
• How can we integrate biomarkers, advanced imaging, and AI-driven computational models to predict therapeutic response in Alzheimer’s and Parkinson’s disease?

This conference is a call to refine our tools and bridge the gap between mechanism and intervention. As we move from neuroinflammation to neurointervention, we are not merely mapping pathways—we are building bridges: between academia, clinical science, industry, government, and advocacy communities.

Join us as more than 250 members of the interdisciplinary neuroscience community—spanning neurology, psychiatry, immunology, psychology, neurosurgery, and translational research—come together to transform neuroinflammation from a diagnostic clue into a therapeutic opportunity.